Gastrointestinal And Metabolic Effects From a Prebiotic, Lifting, and Aerobic iNtervention (GAMEPLAN)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Overweight and Obesity
- Sponsor
- University of Illinois at Urbana-Champaign
- Enrollment
- 48
- Locations
- 1
- Primary Endpoint
- Changes in gastrointestinal microbiota composition
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
This study aims to determine the independent and combined effects of prebiotic fiber supplementation and exercise on the gut microbiome and human health.
Investigators
Eligibility Criteria
Inclusion Criteria
- •BMI 18.5-45 kg/m2
- •Without physician diagnosed gastrointestinal or metabolic diseases
- •Sedentary (\< 30 minutes of moderate or high intensity exercise per week OR \< 20 aggregate Godin-Shepard Leisure Time Physical Activity Questionnaire (GSLTQ; GodinLeisure) score)
- •Fully vaccinated against COVID-19
Exclusion Criteria
- •Fasting blood glucose \>126 mg/dL
- •Blood pressure \>160/100 mm Hg
- •Physician diagnosed metabolic or gastrointestinal diseases or constipation
- •Heart conditions that may pose risk during exercise
- •Taking oral hypoglycemic agents or insulin
- •Pregnant, breastfeeding or postmenopausal
- •Smoke or consume \> 2 alcoholic beverages/day, abuse drugs
- •Have had \> 5% weight change in the past month or \> 10% change in the past year
- •Have had any form of bariatric surgery or gallbladder removal
- •Have taken antibiotics during the previous 3 months
Outcomes
Primary Outcomes
Changes in gastrointestinal microbiota composition
Time Frame: Baseline & 6-week mark
Determine the impact of daily consumption of prebiotic combined with regular exercise on the gastrointestinal microbiota compared to control by sequencing the V4 region of the 16S rRNA gene in fecal samples.
Changes in gastrointestinal microbial-derived metabolite concentrations
Time Frame: Baseline & 6-week mark
Determine the impact of daily consumption of prebiotic combined with regular exercise on the concentration of short-chain fatty acids compared to control.
Secondary Outcomes
- Changes in fasting insulin(Baseline & 6-week mark)
- Changes in body composition(Baseline & 6-week mark)
- Changes in fasting glucose(Baseline & 6-week mark)
- Changes in body fat distribution(Baseline & 6-week mark)
- Changes in cognition(Baseline & 6-week mark)